Disc Medicine Inc. (IRON)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.64B
Last updated: Nov 17, 2026 at 11:06 AM ET
Disc Medicine Inc. (IRON) Stock Forecast
Analysts expect Disc Medicine (IRON) to earn -$5.99 per share in the fiscal year ending Dec 31, 2026. Of 13 analysts, 13 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 13 ratings average 1.92, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 7.7% |
| Buy | 12 | 92.3% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 13
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss.
- Fiscal year ending Dec 31, 2026
- -$5.99
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$6.33
- EPS consensus, revenue $43.98M
- Next report
- Feb 24, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$5.99 | -$6.44 to -$5.11 | 6 | N/A | N/A | 12 |
| Dec 31, 2027 | -$6.33 | -$7.22 to -$5.56 | 8 | $43.98M | $6.53M to $180.00M | 13 |
Quarterly Estimates
The EPS consensus rises from -$1.80 for the quarter ending Dec 31, 2026 to -$1.66 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.80 | -$2.21 to -$1.46 | 14 |
| Mar 31, 2027 | -$1.66 | -$1.91 to -$1.45 | 7 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 6 upward and 7 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 2 |
| Fiscal year ending Dec 31, 2027 | 4 | 3 |
| Quarter ending Mar 31, 2027 | 1 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$6.67.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$5.99 | -$6.55 | -$6.56 | -$6.67 | -$6.67 | N/A |
| Fiscal year ending Dec 31, 2027 | -$6.33 | -$6.82 | -$7.08 | -$7.26 | -$7.27 | N/A |
| Quarter ending Mar 31, 2027 | -$1.66 | -$1.83 | -$1.82 | -$1.87 | -$1.86 | N/A |
Frequently Asked Questions About IRON
What is the IRON stock forecast?
Consensus analyst estimates put Disc Medicine's EPS at -$5.99 for the fiscal year ending Dec 31, 2026. The consensus rating from 13 analysts is Buy.
How do analysts rate IRON stock?
Of 13 analysts covering Disc Medicine, 1 rates it Strong Buy, 12 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from IRON next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$5.99, with estimates from -$6.44 to -$5.11 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$6.33, with estimates from -$7.22 to -$5.56 from 8 analysts.
What revenue do analysts expect from Disc Medicine next year?
For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $43.98M, with estimates from $6.53M to $180.00M.
How many analysts cover IRON?
13 analysts rate Disc Medicine stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
IRON pages: Overview, Earnings, Forecast, Financials, Competitors